除FDG以外的用于肿瘤PET显像的<sup>18</sup>F标记物

罗全勇

除FDG以外的用于肿瘤PET显像的¹⁸F标记物

罗全勇

文章导航 > 国际放射医学核医学杂志 > 2001, 25 > 6: (249-253)

引用本文:

Citation:

除FDG以外的用于肿瘤PET显像的¹⁸F标记物

罗全勇

200233 上海, 上海市第六人民医院核医学科

作者简介: 罗全勇(1972-),男,四川隆昌人,上海市第六人民医院核医学科住院医师,上海第二医科大学核医学专业硕士研究生,主要从事核素诊断与治疗的研究。;

中图分类号: R817.4

¹⁸F-labeled radiopharmaceuticals(excluding FDG) for PET in oncology

LUO Quan-yong

Nuclear Medicine Department of Shanghai Sixth People's Hospital, Shanghai 200233, China
CLC number: R817.4

摘要: 综述了除FDG以外的用于肿瘤PET显像的¹⁸F标记物的研究和应用。这些¹⁸F标记物主要包括:与相应受体结合的¹⁸F标记的蛋白质和多肽,¹⁸F标记的乏氧显像剂,用于评价基因治疗的¹⁸F标记物等。此外,还介绍了用于诊断不同恶性肿瘤的¹⁸F标记的组织特异性PET显像剂。
- 正电子发射断层显像 /
- ¹⁸F标记物 /
- 肿瘤学
Abstract: This article reviews possible use of ¹⁸F-labeled radiopharmaceuticals (excluding FDG) in oncology with positron emission tomography. The characteristics of various ¹⁸F-labeled compounds are proteins and peptides, those that bind to receptors, agents to assess hypoxia, and agents to evaluate gene therapy. Furthermore, different ¹⁸F-labeled tissue specific agents are indicated for the detection and monitoring of various malignancies.
- positron emission tomography /
- ¹⁸F-labeled compound /
- oncology
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Wester HJ, Hamacher K, Stocklin G.A comparative study of NCA fluoro-18 labeling of protein via acylation and photochemical conjugation[J].Nucl Med Biol, 1996, 23:365-372.
[2]	Collier TL, O'Brien JC, Waterhouse RN.Synthesis of [¹⁸F] 1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl) piperidine:A potential sigma-l receptor radioligand for PET[J].J Labelled Compd Radiopharm, 1996, 38:785-794.
[3]	Liu RS, Chu LS, Yen SH, et al.Detection of anaerobic odonogenic infections by fluorine-18 fluoromisnidazole[J].Eur J Nucl Med, 1996, 23:1384-1387.
[4]	Tewson T J, Synthesis of [¹⁸F]fluoroetanidazole:Apotential new tracer for imaging hypoxia[J].Nucl Med Biol, 1997, 24:755-760.
[5]	Gambhir SS, Barrio JR, Phelps ME, et al.Imaging adenoviral-directed reporter gene expression in living animals with positron emssion tomography[J].Proc Natl Acad Sci USA, 1999, 96:2333-2338.
[6]	Alauddin MM, Conti PS, Mazza SM, et al.¹⁸F-FHPG:A potential imaging agent of viral infection and gene therapy using PET[J].Nucl Med Biol, 1996, 23:787-792.
[7]	Tomiyoshi K, Amed K, Muhammad S, et al.Synthesis of isomers of ¹⁸F-labeled amino acid radiopharmaceutical:position 2-and 3-L-¹⁸F-alpha-methyltyrosine using a separation and purification system[J].Nucl Med Commun, 1997, 18:169-175.
[8]	Wester HJ, Herz M, Weber W, et al.Sythesis and radiopharmacology of O-(2-[¹⁸F] fluorethyl)-L-tyrosine for tumor imaging[J].J Nucl Med, 1999, 40:205-212.
[9]	Shoup TM, Olson J, Hoffinan JM, et al.Sythesis and evaluation of [¹⁸F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors[J].J Nucl Med, 1999, 40:331-338.
[10]	Eigtved A, Jensen M, Holm B, et al.[¹⁸F]Fluoro-5dihydrotestosterone as a PET ligand for androgen receptors in prostate cancer[J].J Nucl Med, 1999, 40:256P.
[11]	Kissel J, Brix G, Bellemann ME, et al.Pharmacokinetic analysis of 5-[¹⁸F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma[J].Cancer Res, 1997, 57:3415-3423.

[1]	彭添兴 , 吴华 . ¹⁸F-氟脱氧葡萄糖以外新型PET肿瘤显像剂. 国际放射医学核医学杂志, 2007, 31(1): 9-12.
[2]	耿建华 , 陈英茂 . 正电子图像的定量分析在临床肿瘤学中的应用. 国际放射医学核医学杂志, 2005, 29(1): 6-9.
[3]	王淑侠 , 裴著果 . 当代临床PET热点与最新发展动态. 国际放射医学核医学杂志, 2000, 24(6): 241-245.
[4]	李林 . ¹⁸F-FDG PET显像在肿瘤学中的应用. 国际放射医学核医学杂志, 2000, 24(6): 254-258.
[5]	唐刚华 . 基因表达正电子发射断层显像. 国际放射医学核医学杂志, 2001, 25(6): 241-245.
[6]	康玉国 . 分化型甲状腺癌¹⁸F-FDG PET显像的临床应用. 国际放射医学核医学杂志, 2000, 24(6): 264-267.
[7]	张立颖 . ¹⁸F-FDG PET显像在恶性淋巴瘤中的应用. 国际放射医学核医学杂志, 2001, 25(1): 10-12.
[8]	管梁 , 吕中伟 . ¹⁸F-FDG PET显像在鉴别胰腺良恶性肿块中的应用价值. 国际放射医学核医学杂志, 2000, 24(6): 259-263.
[9]	李亚军 , 白人驹 , 高硕 , 李彦生 , 刘磊 , 贾薇 , 蔡莉 , 邢喜玲 . 兔VX2肺肿瘤PET-CT与血管生成的相关性研究. 国际放射医学核医学杂志, 2010, 34(3): 139-142. doi: 10.3760/cma.j.issn.1673-4114.2010.03.003
[10]	王瑞民 . 阿尔茨海默病等痴呆疾病的脑功能影像学研究. 国际放射医学核医学杂志, 2001, 25(5): 209-212.